NCT00362180 - Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

March 31, 2010

Study Completion Date

September 30, 2010

Conditions

Lipid Metabolism, Inborn ErrorsHyperlipidemiasMetabolic DiseasesHypolipoproteinemiaHypolipoproteinemiasHypobetalipoproteinemiasMetabolism, Inborn ErrorsGenetic Diseases, InbornInfant, Newborn, DiseasesCongenital AbnormalitiesMetabolic DisorderHypercholesterolemiaDyslipidemiasLipid Metabolism Disorders

Interventions

DRUG

mipomersen

200 mg subcutaneous injections

DRUG

Placebo

subcutaneous injections

Trial Locations (1)

1105 AZ

Amsterdam